Dorman Products, Inc. New (DORM) is a publicly traded Consumer Cyclical sector company. As of November 13, 2026, DORM trades at $132.00 with a market cap of $3.97B and a P/E ratio of 17.34. DORM moved -0.00% today. Year to date, DORM is +5.28%; over the trailing twelve months it is -4.38%. Its 52-week range spans $98.45 to $166.89. Analyst consensus is strong buy with an average price target of $157.00. Rallies surfaces DORM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Dorman cuts 2026 sales growth outlook to 2%-3%: Dorman Products’ third-quarter 2026 diluted EPS fell 20% to $1.98, while net sales rose to $561.7 million. The company cut 2026 net sales growth guidance to 2%-3% and narrowed diluted EPS expectations to $7.95-$8.15.
| Metric | Value |
|---|---|
| Price | $132.00 |
| Market Cap | $3.97B |
| P/E Ratio | 17.34 |
| EPS | $7.25 |
| Dividend Yield | 1.50% |
| 52-Week High | $166.89 |
| 52-Week Low | $98.45 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.16B |
| Net Income | $219.30M |
| Gross Margin | 42.31% |
5 analysts cover DORM: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $157.00.